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Abstract 
Purpose 
This study was designed to determine the role of laparoscopic adrenalectomy (LA) in the surgical 
management of adrenocortical carcinoma (ACC). 
Methods 
A systematic literature review was performed on January 2, 2015 using PubMed. Article selection 
proceeded according to PRISMA criteria. Studies comparing open adrenalectomy (OA) to LA for 
ACC and including at least 10 cases per each surgical approach were included. Odds ratio (OR) was 
used for all binary variables, and weight mean difference (WMD) was used for the continuous 
parameters. Pooled estimates were calculated with the fixed-effect model, if no significant 
heterogeneity was identified; alternatively, the random-effect model was used when significant 
heterogeneity was detected. Main demographics, surgical outcomes, and oncological outcomes 
were analyzed. 
Results 
Nine studies published between 2010 and 2014 were deemed eligible and included in the analysis, 
all of them being retrospective case–control studies. Overall, they included 240 LA and 557 OA 
cases. Tumors treated with laparoscopy were significantly smaller in size (WMD −3.41 cm; 
confidence interval [CI] −4.91, −1.91; p < 0.001), and a higher proportion of them (80.8 %) more at 
a localized (I–II) stage compared with open surgery (67.7 %) (odds ratio [OR] 2.8; CI 1.8, 4.2; 
p < 0.001). Hospitalization time was in favor of laparoscopy, with a WMD of −2.5 days (CI −3.3, 
−1.7; p < 0.001). There was no difference in the overall recurrence rate between LA and OA 
(relative risk [RR] 1.09; CI 0.83, 1.43; p = 0.53), whereas development of peritoneal carcinomatosis 
was higher for LA (RR 2.39; CI 1.41, 4.04; p = 0.001). No difference could be found for time to 
recurrence (WMD −8.2 months; CI −18.2, 1.7; p = 0.11), as well as for cancer specific mortality 
(OR 0.68; CI 0.44, 1.05; p = 0.08). 
Conclusions 
OA should still be considered the standard surgical management of ACC. LA can offer a shorter 
hospital stay and possibly a faster recovery. Therefore, this minimally invasive approach can 
certainly play a role in this setting, but it should be only offered in carefully selected cases to avoid 
jeopardizing the oncological outcome. 
On the behalf of Italian Endourological Association (IEA) Research Office and International 
Translational Research in Uro-Sciences Team (ITRUST). 
Adrenocortical carcinoma (ACC) represents a rare but rather aggressive tumor,1 often associated 
with poor prognosis, despite aggressive multimodality treatment.2 Surgical resection has 
traditionally been paying a major role in the management of the disease, especially in its early 
stages, where there might still be a window for cure.3 Laparoscopic adrenalectomy was first 
reported by Gagner et al. 1992 and since then rapidly implemented for the resection of functioning 
and non functioning adrenal masses, given the recognized advantages in terms of postoperative 
morbidity and hospital stay compared with open surgery.4–6 More recently, the role of robot-
assisted laparoscopy has been postulated for adrenal surgery.7 
Laparoscopic surgery for malignant adrenal tumors also has been explored, but its role remains 
highly debated, given concerns regarding the quality of surgical resection and related oncological 
risks.8–10 In case of ACC, several laparoscopic series have been reported, with conflicting results. 
According to contemporary guidelines open surgery should be regarded as the standard treatment of 
patients with localized (stage I–II)/locally advanced (stage III) ACC, whereas laparoscopic 
adrenalectomy can be pursued in selected patients with small ACCs (<8 cm) without preoperative 
evidence for invasiveness. Moreover, this technique should be ideally performed in centers with a 
consolidated experience in laparoscopic adrenal surgery.11,12 
The goal of this study was to provide a systematic review and meta-analysis of available 
comparative studies assessing laparoscopic adrenalectomy (LA) versus open adrenalectomy (OA) 
for the surgical resection of ACC. 
Methods 
Literature Search and Studies Selection 
A computerized systematic literature search was performed by using the PubMed database to 
identify studies published as of January 2, 2015. The following search free text terms were used: 
“laparoscopic adrenalectomy” OR “adrenocortical carcinoma.” Only studies that meet the 
following eligibility criteria were included: original study, comparing OA to LA for the specific 
indication ACC, including at least 10 cases per study group, and allowing data extraction of 
relevant outcomes. Identification and selection of the studies was conducted according to Preferred 
Reporting Items for Systematic Reviews and Meta-analysis criteria (www.prisma-statement.org). 
All titles were screened for manuscripts written in the English language, and only on adult patients. 
Titles of articles were first reviewed to ascertain whether they might potentially fit the inclusion 
criteria. After assessing the abstract, a more thorough subsequent assessment was performed by 
looking at full text. 
Study Quality Assessment 
Because none of them was a randomized controlled trial, the methodological quality of the studies 
was rated according the Newcastle–Ottawa Scale (NOS) for observational retrospective studies.13 
The level of evidence was reported as described by the Oxford Center for Evidence-Based 
Medicine.14 
Outcomes of Interest 
The following relevant parameters were assessed: demographics, including patients’ age, tumor 
characteristics (clinical presentation, size, stage, Weiss score 15); surgical outcomes (operative 
time, postoperative major (Clavien grade >2) complication rate, hospital stay, R0 surgical margins 
status, use of adjuvant therapy—defined as any form of adjuvant therapy, such as chemotherapy, 
mitotane, radiation therapy), and oncological outcomes (rate of recurrence—defined as clinical, 
laboratory, or radiologic evidence of disease recurrence; time to recurrence—defined as the time 
between surgery and occurrence of disease recurrence; rate of cancer specific mortality—defined as 
number of deaths, with cancer as the underlying cause of death, occurring in the study population 
during the follow-up period). 
Statistical Analysis 
A meta-analysis of extractable data was performed. Odds ratio (OR) was used for all binary 
variables, and weight mean difference (WMD) was used for the continuous parameters. For the 
studies presenting continuous data as means and range, estimated standard deviations were 
calculated using the methodology described by Hozo et al.15 Pooled estimates were calculated with 
the fixed-effect model (Mantel–Haenszel method), if no significant heterogeneity was identified; 
alternatively, the random-effect model (DerSimonian–Laird method) was used when significant 
heterogeneity was detected.16,17 The final pooled effects were reported by the z test, and p < 0.05 
was considered as statistically significant. To assess the heterogeneity among the included studies, 
the Cochrane χ2 test and inconsistency (I2) were used. Evaluation of potential publication bias was 
done by funnel plots analysis for each outcome. The data analysis was performed using the Review 
Manager software (Revman v.5.2.8, Cochrane Collaboration, Oxford, UK). 
Results 
The initial search yielded 2070 and 2566 records, whose titles were screened. After initial screening 
and removal of duplicates, 24 articles were considered and reviewed based on title and abstract. At 
the end of the process, nine studies were reviewed in full text and confirmed to meet eligibility 
criteria (Fig. 1).18–26 
 
Fig. 1 
PRISMA flow diagram illustrating the study selection process 
An overview of the studies, all published between 2010 and 2014, is provided in Table 1. Overall, 
the quality of studies was high, despite all being retrospective case–control studies with a low level 
of evidence. 
Table 1 
Characteristics and quality assessment of the included studies 
Study 
Study 
period 
No. of cases 
(OA:LA) 
Tumor 
stage 
Study design 
Level of 
evidence
a
 
Quality 
score
b
 
Porpiglia 
18 
2002–
2008 
25:18 I/II only 
Retrospective case 
control 
4 8/9 
Miller 19 
2003–
2008 
71:17 I–III 
Retrospective case 
control 
4 8/9 
Brix 20 1996– 117:35 I–III Retrospective case 4 9/9 
Study 
Study 
period 
No. of cases 
(OA:LA) 
Tumor 
stage 
Study design 
Level of 
evidence
a
 
Quality 
score
b
 
2009 control 
Lombardi 
21 
2003–
2010 
126:30 I–II 
Retrospective case 
control 
4 8/9 
Miller 22 
2005–
2011 
110:46 I–III 
Retrospective case 
control 
4 8/9 
Mir 23 
1993–
2011 
26:18 I–IV 
Retrospective case 
control 
4 8/9 
Fossa 24 
1998–
2011 
15:17 I–III 
Retrospective case 
control 
4 8/9 
Cooper 25 
1993–
2012 
46:46 I–IV 
Retrospective case 
control 
4 8/9 
Donatini 
26 
1985–
2011 
21:13 I/II only 
Retrospective case 
control 
4 8/9 
OA open adrenalectomy, LA laparosocpic adrenalectomy 
a
Oxford criteria 
b
Newcastle–Ottawa scale 
Demographics 
Patients undergoing OA were older than those submitted to LA (WMD 2.56 years; CI 0.78, 4.34; 
p = 0.005). In four studies the clinical presentation of the adrenal tumor was described, and a higher 
rate of incidentalomas was found in the LA group (43 %) versus the OA group (31.8 %) (OR 2.39; 
CI 1.39, 4.12; p = 0.002).18,20,21,24 Tumors treated with laparoscopy were significantly smaller in 
size (WMD −3.41 cm; CI −4.91, −1.91; p < 0.001), and a higher proportion of them (80.8 %) more 
at a localized (I–II) stage compared to open surgery (67.7 %) (OR 2.8; CI 1.8, 4.2; p < 0.001). The 
Weiss score, which was available in four studies only, was similar between the two groups (WMD 
−0.01, CI −0.27, 0.25; p = 0.95).18,20,23,26 
Surgical Outcomes (Fig. 2) 
Data related to operative time were available for analysis in three studies, and no difference could 
be detected between the two techniques (p = 0.85).21,23,24 EBL was reported in two studies only, 
and no difference could be detected (p = 0.48).23,24 Postoperative complication rate was available 
in four studies, and, again, there was no difference between laparoscopy and open surgery 
(p = 0.14).21,23,24,26 In the same four studies, the hospitalization time was reported, and this was 
consistently in favor of laparoscopy, with a WMD of −2.5 days (CI −3.3, −1.7; 
p < 0.001).21,23,24,26 There was no difference in the rate of negative surgical margins (R0), which 
was reported in seven of the studies (61.9 % for LA, 57.6 % for OA; p = 0.98).19,20,22–26 
Adjuvant therapy was used in a similar proportion of cases for LA and OA (32.5 and 29.8 %, 
respectively; p = 0.91).20,21,23,25 The funnel plots suggested no publication bias, so that 
heterogeneity is most likely explained by other differences between the studies, such as study 
design, patient selection, and outcome assessment. 
 
Fig. 2 
Forrest and funnel plots for surgical outcomes a Operative time, b estimated blood loss (EBL), c 
postoperative complication rate, d hospital stay 
Oncological Outcomes (Fig. 3) 
There was no difference in the overall recurrence rate between LA and OA (RR 1.09; CI 0.83, 1.43; 
p = 0.53).18–26 In five studies, investigators looked at the development of peritoneal 
carcinomatosis at the time of recurrence, and there was an overall higher risk for LA versus OA 
(RR 2.39; CI 1.41, 4.04; p = 0.001).19,20,23–25 
 
Fig. 3 
Forrest and funnel plot for oncological outcomes a Overall recurrence rate, b Peritoneal 
carcinomatosis at recurrence, c Time to recurrence, d Cancer specific mortality rate 
Time to recurrence was reported in four studies only, and, also for this outcome, no significant 
difference could be detected between LA and OA (WMD −8.2 months; CI −18.2, 1.7; 
p = 0.11).19,21–23 Cancer-specific mortality was available for analysis in six of the studies, and, 
again, no significant difference was found (OR 0.68; CI 0.44, 1.05; p = 0.08).18,20,21,23,25, 26 
Also for these outcomes, the funnel plots suggested no publication bias, but rather heterogeneity 
related to other confounders related to study design. 
Discussion 
An appropriate surgical resection is a mandatory step in the therapeutic management of ACC. Thus, 
the role of minimally invasive surgery for this specific indication is still under scrutiny, as data 
supporting its implementation remain scanty and controversial outcomes have been reported.12 A 
recent analysis of the large National Inpatient Sample database has suggested that the use of 
laparoscopic techniques to perform adrenalectomy has increased at a slower rate over the last 
decade when compared with other procedures.27 
The present systematic review and meta-analysis provides the best currently available evidence on 
the comparative outcomes of laparoscopy versus open surgery for the surgical resection of ACC 
with the aim of determining to what extent a minimally invasive approach should be considered in 
this setting. 
Few findings of our analysis are of worth of consideration. First and foremost, the fact that a limited 
number of comparative studies are available, most of them with a limited number of cases, 
especially for the laparoscopic cohorts, which reflects the rarity of the disease. Moreover, despite 
being of good quality, all of these studies are retrospective case–control series, implying a patient 
selection bias and other intrinsic limitations related to their design. Nevertheless, the lack of 
randomized trial is recognized as a common drawback of clinical investigation for any surgical 
specialty. The two largest studies comparing LA to OA are based on multi-institutional analyses, 
namely the one reported by the German Adrenocortical Carcinoma Registry Group and the one 
based on an Italian multi-institutional survey.20,21 In both studies, the ratio open:laparoscopic 
cases was approximately 3:1, which suggest that in these specialized centers there has been a 
selective implementation of laparoscopy. Both studies concluded that oncologic outcomes are not 
jeopardized if proper patient selection is embraced and principles of oncological radicality are 
respected. 
Not surprisingly, we found that patients undergoing OA were on approximately 2.5 years older than 
those submitted to LA (p = 0.005). Moreover, tumors treated with LA are more likely to represent 
incidental diagnosis (p = 0.002), smaller in size (p < 0.001), and a localized (I–II) stage compared 
with OA (p < 0.001). On the other hand, in six of the nine comparative studies, cases of 
nonlocalized ACC (stage III–IV) were included,19,20,22–25 which can reflect the status of referral 
centers reporting the studies. Center volume and surgical experience play a crucial role in the 
oncologic outcome of patients with adrenal malignancies; it has been suggested that adrenal cancer 
surgery should be performed only in centers with >10 cases per year.28 
No significant differences could be found in terms of main surgical parameters (operative time, 
EBL, and complication rate) between LA and OA. The lack of significant difference in terms of 
operative time can be regarded as an unexpected finding especially considering the need for 
adjacent organ removal that is very time consuming step, and it was probably more extensive in the 
open surgery cases. To note, the surgical outcome “operative time” could be retrieved only in one 
third of the studies included in the meta-analysis. Thus, there might have certainly been a case 
selection bias. In addition, we could not assess in this setting the impact of the “learning curve” 
factor. In other words, the surgical experience of the different surgeons from the different studies 
might have played a role. Also, when considering that most of these are academic institutions, one 
can speculate that residents/fellows were involved in portions of the cases, thus impacting the 
duration of surgery. 
Hospitalization time was clearly in favor of laparoscopy, with a statistical (p < 0.001) but also 
clinically significant difference (WMD of −2.5 days). The concept that laparoscopic surgery 
shortens hospital stay and likely enables a faster return to normal daily activities has been largely 
demonstrated for a variety of urologic diseases.29 
The importance of complete, en bloc, margin-negative resection of ACC in patients who are fit to 
undergo surgery is a consolidated principle. In a large analysis from the national cancer database, 
Bilimoria et al. showed that median survival for patients with margin-negative resection was 
51.2 months, whereas it was only 7 months for those who underwent margin positive resection.30 
We found no difference in the rate of negative surgical margins, which was reported in seven of the 
studies (61.9 % for LA, 57.6 % for OA; p = 0.98).19,20,22–26 
The aggressive behavior of ACC provided the rationale for the use of adjuvant therapy, either 
radiotherapy to the tumor bed or mitotane.31 We found that adjuvant therapy (any form) was used 
in a similar proportion of cases for LA and OA (32.5 and 29.8 %, respectively; p = 0.91) 
20,21,23,25; however, this finding is difficult to interpreter as different Centers might have adopted 
different therapeutic criteria. 
In the only available meta-analysis of studies comparing LA versus OA for ACC, Sgourakis et al. 
looked at the oncological outcomes for stage I/II disease.32 They included four comparative 
studies, all of them also included in our meta-analysis.18,21,24,26 The authors found that OA 
seems to provide better survival rates at 5 years. This finding resembles those reported by Miller et 
al., who reviewed the single-institution experience with the surgical treatment of 217 cases of ACC 
(stage I–III).19 Overall survival for patients with stage II cancer was longer in those undergoing 
OA. Moreover, time to local or peritoneal recurrence was shorter in those treated laparoscopically. 
We could not find differences for most relevant oncological outcomes between LA and OA, namely 
the overall recurrence rate (p = 0.53), time to recurrence (p = 0.11), and cancer-specific mortality 
(p = 0.08). However, there was a higher risk of development of peritoneal carcinomatosis at the 
time of recurrence for LA (RR 2.39; CI 1.41, 4.04; p = 0.001). This finding is in line with the study 
by Leboulleux et al., who found the surgical approach to be related to the risk of peritoneal 
carcinomatosis,33 as well as data reported by Gonzalez et al. who observed peritoneal 
carcinomatosis in 5 of the 6 patients (83 %) who underwent laparoscopic resection of ACC in their 
series.10 Considering that patients with ACC recurrence seem to have higher survival rates if 
amenable to complete surgical resection and the presence of peritoneal recurrence is likely to 
compromise a salvage surgery, these findings support the concept that a complete oncological 
resection remains the key factor, and it should not be compromised by the implementation of a 
minimally invasive approach. 
The major limitation of this meta-analysis is related to the retrospective design of included studies, 
which allowed the analysis to be necessarily limited to certain parameters. Thus, it was not possible 
to perform a more detailed separate analysis of oncological outcomes (local recurrence only versus 
distant recurrence only versus peritoneal carcinomatosis only versus a combination of these events). 
Similarly, it was not possible to weight the impact of the different forms of adjuvant therapy used in 
the different studies. Moreover, it is not possible to account for existing differences among centers 
in terms of surgical techniques, as well as protocols of perioperative management and oncological 
follow-up. Despite these limitations, we are able to provide the best available evidence in the field, 
as nine studies with more than 700 ACC cases were included in the analysis. Thus, our findings can 
be used as reference for further clinical investigation. 
Last, the role of robot-assisted laparoscopy in this setting remains to be determined. Robot-assisted 
laparoscopy is being implemented for adrenal surgery and recent evidence suggests that robotic 
adrenalectomy can be performed safely and effectively with potential advantages of a shorter 
hospital stay, less blood loss, and lower occurrence of postoperative complications.7 Data on the 
use of robotics for large adrenal masses remain scanty, but early series are encouraging.34 
Conclusions 
OA should be still considered the standard for the surgical management of ACC, as it allows proper 
radical extirpation of the disease. LA can offer a shorter hospital stay, possibly allowing a quicker 
postoperative recovery, and it can certainly have a complementary role in this setting. However, this 
minimally invasive approach should be only offered in carefully selected ACC cases and by centers 
with appropriate laparoscopic expertise in order to avoid jeopardizing the oncological outcome. 
References 
1. 1. 
Else T, Kim AC, Sabolch A, et al. Adrenocortical carcinoma. Endocr Rev. 2014;35(2):282–
32.CrossRefPubMedPubMedCentralGoogle Scholar 
2. 2. 
Gratian L, Pura J, Dinan M, et al. Treatment patterns and outcomes for patients with 
adrenocortical carcinoma associated with hospital case volume in the United States. Ann 
Surg Oncol. 2014;21(11):3509–14.CrossRefPubMedPubMedCentralGoogle Scholar 
3. 3. 
Carnaille B. Adrenocortical carcinoma: which surgical approach? Langenbecks Arch Surg. 
2012;397(2):195–9.CrossRefPubMedGoogle Scholar 
4. 4. 
Gagner M, Lacroix A, Bolté E. Laparoscopic adrenalectomy in Cushing’s syndrome and 
pheochromocytoma. N Engl J Med. 1992;327(14):1033.CrossRefPubMedGoogle Scholar 
5. 5. 
Greco F, Hoda MR, Rassweiler J, et al. Laparoscopic adrenalectomy in urological centres - 
the experience of the German Laparoscopic Working Group. BJU Int. 2011;108(10):1646–
51.CrossRefPubMedGoogle Scholar 
6. 6. 
Elfenbein DM, Scarborough JE, Speicher PJ, Scheri RP. Comparison of laparoscopic versus 
open adrenalectomy: results from American College of Surgeons-National Surgery Quality 
Improvement Project. J Surg Res. 2013;184(1):216–20.CrossRefPubMedGoogle Scholar 
7. 7. 
Brandao LF, Autorino R, Laydner H, et al. Robotic versus laparoscopic adrenalectomy: a 
systematic review and meta-analysis. Eur Urol. 2014;65(6):1154–
61.CrossRefPubMedGoogle Scholar 
8. 8. 
Moinzadeh A, Gill IS. Laparoscopic radical adrenalectomy for malignancy in 31 patients. J 
Urol. 2005;173(2):519–25.CrossRefPubMedGoogle Scholar 
9. 9. 
Porpiglia F, Fiori C, Tarabuzzi R, et al. Is laparoscopic adrenalectomy feasible for 
adrenocortical carcinoma or metastasis? BJU Int. 2004;94(7):1026–
9.CrossRefPubMedGoogle Scholar 
10. 10. 
Gonzalez RJ, Shapiro S, Sarlis N, et al. Laparoscopic resection of adrenal cortical 
carcinoma: a cautionary note. Surgery. 2005;138(6):1078–85.CrossRefPubMedGoogle 
Scholar 
11. 11. 
Berruti A, Baudin E, Gelderblom H, et al. Adrenal cancer: ESMO Clinical Practice 
Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23(Suppl 7):vii131–8. 
12. 12. 
Stefanidis D, Goldfarb M, Kercher KW, Hope WW, Richardson W, Fanelli RD; Society of 
Gastrointestinal and Endoscopic Surgeons. SAGES guidelines for minimally invasive 
treatment of adrenal pathology. Surg Endosc. 2013;27(11):3960–
80.CrossRefPubMedGoogle Scholar 
13. 13. 
Wells GA, Shea B, O’Connell D, et al. The Newcastle Ottawa 1 Scale (NOS) for assessing 
the quality of nonrandomized studies in meta-analyses. 
http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. 
14. 14. 
Phillips B, Ball C, Sackett D, et al. Levels of evidence and grades of recommendation. 
Oxford Centre for Evidence-Based Medicine—Levels of Evidence (March 2009). 
http://www.cebm.net/index.aspx?o=1025. 
15. 15. 
Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, 
and the size of a sample. BMC Med Res Methodol. 
2005;5:13.CrossRefPubMedPubMedCentralGoogle Scholar 
16. 16. 
Matel N, Haenszel W, Statistical aspects of the analysis of data from retrospective studies of 
disease. J Natl Caner Inst. 1959;22(4):719–48.Google Scholar 
17. 17. 
DerSimonian R, Laird N, Meta-analysis in clinical trials. Control Clin Trials. 
1986;7(3):177–88.CrossRefPubMedGoogle Scholar 
18. 18. 
Porpiglia F, Fiori C, Daffara F, et al. Retrospective evaluation of the outcome of open versus 
laparoscopic adrenalectomy for stage I and II adrenocortical cancer. Eur Urol. 
2010;57(5):873–8.CrossRefPubMedGoogle Scholar 
19. 19. 
Miller BS, Ammori JB, Gauger PG, Broome JT, Hammer GD, Doherty GM. Laparoscopic 
resection is inappropriate in patients with known or suspected adrenocortical carcinoma. 
World J Surg. 2010;34(6):1380–5.CrossRefPubMedGoogle Scholar 
20. 20. 
Brix D, Allolio B, Fenske W, et al. Laparoscopic versus open adrenalectomy for 
adrenocortical carcinoma: surgical and oncologic outcome in 152 patients. Eur Urol. 
2010;58(4):609–15.CrossRefPubMedGoogle Scholar 
21. 21. 
Lombardi CP, Raffaelli M, De Crea C, et al. Open versus endoscopic adrenalectomy in the 
treatment of localized (stage I/II) adrenocortical carcinoma: results of a multiinstitutional 
Italian survey. Surgery. 2012;152(6):1158–64.CrossRefPubMedGoogle Scholar 
22. 22. 
Miller BS, Gauger PG, Hammer GD, Doherty GM. Resection of adrenocortical carcinoma is 
less complete and local recurrence occurs sooner and more often after laparoscopic 
adrenalectomy than after open adrenalectomy. Surgery. 2012;152(6):1150–
7.CrossRefPubMedGoogle Scholar 
23. 23. 
Mir MC, Klink JC, Guillotreau J, et al. Comparative outcomes of laparoscopic and open 
adrenalectomy for adrenocortical carcinoma: single, high-volume center experience. Ann 
Surg Oncol. 2013;20(5):1456–61.CrossRefPubMedGoogle Scholar 
24. 24. 
Fosså A, Røsok BI, Kazaryan AM, et al. Laparoscopic versus open surgery in stage I-III 
adrenocortical carcinoma: a retrospective comparison of 32 patients. Acta Oncol. 
2013;52(8):1771–7.CrossRefPubMedGoogle Scholar 
25. 25. 
Cooper AB, Habra MA, Grubbs EG, et al. Does laparoscopic adrenalectomy jeopardize 
oncologic outcomes for patients with adrenocortical carcinoma? Surg Endosc. 
2013;27(11):4026–32.CrossRefPubMedGoogle Scholar 
26. 26. 
Donatini G, Caiazzo R, Do Cao C, et al. Long-term survival after adrenalectomy for stage 
I/II adrenocortical carcinoma (ACC): a retrospective comparative cohort study of 
laparoscopic versus open approach. Ann Surg Oncol. 2014;21(1):284–
91.CrossRefPubMedGoogle Scholar 
27. 27. 
Monn MF, Calaway AC, Mellon MJ, Bahler CD, Sundaram CP, Boris RS. Changing USA 
national trends for adrenalectomy: the influence of surgeon and technique. BJU Int. 
2015;115(2):288–94.CrossRefPubMedGoogle Scholar 
28. 28. 
Lombardi CP, Raffaelli M, Boniardi M, et al. Adrenocortical carcinoma: effect of hospital 
volume on patient outcome. Langenbecks Arch Surg. 2012;397(2):201–
7.CrossRefPubMedGoogle Scholar 
29. 29. 
Gill IS, Clayman RV, McDougall EM. Advances in urological laparoscopy. J Urol. 
1995;154(4):1275–94.CrossRefPubMedGoogle Scholar 
30. 30. 
Bilimoria KY, Shen WT, Elaraj D, et al. Adrenocortical carcinoma in the United States: 
treatment utilization and prognostic factors. Cancer. 2008;113(11):3130–
6.CrossRefPubMedGoogle Scholar 
31. 31. 
Berruti A, Fassnacht M, Baudin E, et al. Adjuvant therapy in patients with adrenocortical 
carcinoma: a position of an international panel. J Clin Oncol. 2010;28:e401–
2.CrossRefPubMedGoogle Scholar 
32. 32. 
Sgourakis G, Lanitis S, Kouloura A, et al. Laparoscopic versus open adrenalectomy for 
stage I/II adrenocortical carcinoma: meta-analysis of outcomes. J Invest Surg. 
2015;28(3):145–52.CrossRefPubMedGoogle Scholar 
33. 33. 
Leboulleux S, Deandreis D, Al Ghuzlan A, et al. Adrenocortical carcinoma: is the surgical 
approach a risk factor of peritoneal carcinomatosis? Eur J Endocrinol. 2010;162(6):1147–
53.CrossRefPubMedGoogle Scholar 
34. 34. 
Agcaoglu O, Aliyev S, Karabulut K, Mitchell J, Siperstein A, Berber E. Robotic versus 
laparoscopic resection of large adrenal tumors. Ann Surg Oncol. 2012;19(7):2288–
94.CrossRefPubMedGoogle Scholar 
 
